LDT Appeal: Looking at the Legal Nuances Behind Potential FDA Actions Following Court Decision
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
"May you live...
From - National Intelligence Report
Kickbacks for genetic test referrals has become a focus of recent federal enforcement action. The most recent case involves…
From - National Intelligence Report
Although it's still a profitable endeavor, enforcing federal health care fraud laws isn't providing the investment returns of yesteryears…
From - National Intelligence Report
As a rule of thumb, FDA approvals are a snapshot applicable only to the product as it exists at the time of review and approval…
From - National Intelligence Report
Risk of federal prosecution for health fraud and abuse applies only when you deal with Medicare, TRICARE or other federal health programs…
From - National Intelligence Report
Fraudulent utilization and billing of urine drug screening first became a priority for federal enforcers since the…
From - National Intelligence Report
A new report from OIG details Medicare Fraud Control Unit (MCFU) enforcement activity in fiscal year…